Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer

HIGHLIGHTS

• who: Satoshi Wasamoto and collaborators from the University of Technology Sydney, Australia have published the research work: Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer, in the Journal: (JOURNAL) of June/30,/2020
• what: This analysis evaluated the clinical effectiveness of first-line AteCE treatment in 84 patients with ED-SCLC at nine Japanese institutions between August 2019 and May 2021.
• how: The cutoff values for GPS NLR or BMI have not been established there are various cutoff values indicated . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.